Study of Intravenous RXDX-107 in Patients With Solid Tumors
Clinical trial NCT02548390 · TERMINATED
Trial details
- NCT number
- NCT02548390
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2016-09-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.